Humana (Humana Inc.) is back in focus after its latest earnings update, which combined higher revenue with slightly weaker net income and a downward revision to its full-year GAAP diluted earnings per share (EPS) outlook. The shift has prompted investors to reassess whether the recent share price strength is justified.
UnitedHealth Group issued a grim 2025 earnings forecast on Tuesday, falling far short of Wall Street’s expectations as high medical costs continue to pressure its insurance business.
08 May 2026-10:59
29 Jul 2025-14:50
